What’s Driving The Growth Of The Biopharma Sector Across South East Asia?

The healthcare industry, particularly the life-science and biopharma sectors, across ASEAN is seeing a shift away from a reliance on overseas expertise and imported products and technology towards a preference for homegrown solutions.

China Remains An Attractive Market For Pharma Investment

Recent developments in the Chinese pharma industry show that multinational pharmaceutical companies continue to view China as an attractive investment market.

Pharmaceutical Products Take Center Stage In US-China Trade

US-China trade in pharmaceuticals has shifted, with significant growth driven by advanced medicines, leading to a nearly 3% share of the trading relationship.

Promising Future For The Global CRO Market With 8.4% CAGR

The global CRO market is set to reach $139.56 billion by 2033 with a CAGR of 8.4% between 2023 and 2033, but non-uniform regulations may hinder its growth.

Germany-Saudi Arabia Tie-Up To Boost Rare Disease Testing

Saudi Arabia and Germany have joined forces aiming to enhance multiomic testing availability for rare diseases, with Lifera providing a $30M loan to Centogene

Medicare Drug Price Negotiations See New Guidance From CMS

The updated guidelines by the Biden Administration will help in getting clarity on how the CMS is going to pick drugs that are a perfect fit for negotiations.